IPO Education Foundation presents the first Executive of the Year award to Charles Dadswell for his committed to the creation, promotion and protection of intellectual property. Charles Dadswell is Senior Vice President and General Counsel of Illumina, where he leads all legal and IP matters. Illumina has become a global leader in genomics and has impacted the industry making advancements in genetic solutions more accessible. Illumina owns or has exclusive licenses to more than 250 patents granted in the U.S., and many additional patents granted worldwide, they value intellectual property protection to safeguard its investments in research and development and resulting technological breakthroughs.
In addition to Mr. Dadswell’s role leading legal and IP matters at Illumina, he is also Illumina’s Chief Compliance Officer, President of the Illumina Corporate Foundation, as well as a member of the Executive Committee and Board of Directors of Biocom. Before joining Illumina, Mr. Dadswell was Vice President, General Counsel for North and Latin America and Corporate Director of Global Intellectual Property at bioMerieux. He was previously General Counsel of BioDelivery Sciences International, a specialty pharmaceutical company, and oversaw US intellectual property in a variety of positions with Glaxo, GlaxoWellcome and GlaxoSmithKline.
Mr. Dadswell received an LL.M. in patent law and trade regulation from The George Washington University Law School, a J.D. from Thomas M. Cooley Law School and a B.S. in Pharmacy from Ferris State University.
Join IPO Education Foundation to celebrate Mr. Dadswell at the 12th annual Awards Dinner on December 12 at the National Building Museum in Washington, DC! For questions about sponsoring the event, please contact Foundation@ipo.org.